Sign in Subscribe
Ecosystems

Vantive Revolutionizes Home Dialysis with HomeAdvantage Ecosystem

Strategic Insights

— 2 min read

Vantive, a renowned vital organ therapy company with a 70-year legacy of kidney care innovation, has introduced HomeAdvantage, a pioneering ecosystem for home dialysis therapies. This fully-integrated system comprises peritoneal dialysis (PD) therapies, supply ordering, technical support services, and robust educational programs, all powered by Vantive CONNECT, a suite of digital solutions. HomeAdvantage will be showcased at the American Society of Nephrology's Kidney Week 2025, highlighting Vantive's commitment to transforming the home dialysis experience and addressing critical barriers to therapy access and adoption.

Key Takeaways:

  • HomeAdvantage is designed to address the underutilization of home dialysis, with only approximately 11% of dialysis patients globally receiving PD at home.
  • The ecosystem combines Vantive's evidence-based technologies to help dialysis patients achieve better outcomes, addressing patients' medical needs and mental and emotional challenges through digital solutions.
  • Vantive's digitally-enabled approach to home therapy has been associated with improved patient adherence to therapy, lower mortality rates, and reduced hospitalization rates for home dialysis patients.
  • HomeAdvantage with Vantive CONNECT offers clinical enablement, patient engagement, success services, and tech-enabled insights, supporting patients and care teams throughout the home therapy journey.
  • The platform includes the Sharesource Connectivity Platform, a two-way remote monitoring platform that provides healthcare professionals with insight into patient treatment data, supporting early intervention and personalized decisions.
  • Studies have shown that Sharesource use has been associated with 45% lower all-cause mortality, 69% lower hospitalization rates, and reduced dropout rates, compared to at-home PD therapy without remote patient monitoring technology.
  • The MyPD patient mobile app enables timely communication with care teams, and has been found to significantly increase patient-clinic communication, with patients rating it highly for usability.
  • HomeAdvantage will provide dedicated registered nurses and qualified technicians to monitor Sharesource treatment data through the PD Telecare program, allowing them to proactively address technique-related issues and alert care teams to clinical insights.
  • Vantive aims to establish a foundation for home therapy innovation and adoption, with a multi-pronged approach and support system to ensure confidence in expanding home dialysis adoption.

Statistics:

  • Only approximately 11% of dialysis patients globally receive peritoneal dialysis (PD) at home.
  • Vantive's digitally-enabled approach to home therapy has been associated with:

+ 45% lower all-cause mortality

+ 69% lower hospitalization rates

+ Reduced dropout rates

  • Studies have found that Sharesource use has been associated with these improved outcomes.
  • The MyPD patient mobile app has been found to significantly increase patient-clinic communication, with patients rating it highly for usability.

Sources:

  • Li PK, Chow KM, Cho Y, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779-797.
  • Paniagua R, Ramos A, Avila M, et al. Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial. Nephrol Dial Transplant. 2025 Feb 28;40(3):588-597.
  • Corzo L, Vesga J, Sanabria M, Rivera A. Clinical outcomes in remote patient monitoring program in automated peritoneal dialysis: a Colombian experience. Neph Dial Trans. 2018;35(3):1151.
  • Cely J, Doria C, Dazzarola MP, et al. Engagement and usability of a mobile health app for peritoneal dialysis patients: A pilot randomized controlled trial. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2025;0(0). doi:10.1177/08968608251339578.

Read more